Hextend 01
Hextend Injection, Solution
Product Images NDC 0409-1555
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hextend (NDC 0409-1555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Hextend 02
Hextend 03
This is a description of a medication called MXTEND. It is a 6% Hetastarch in 1 Lactated Electrolyte Injection for intravenous use only. The medication contains several active ingredients including Hetastarch, Sodium Chloride, Sodium Lactate Anhydrous, Dextrose Hydrous, Calcium Chloride Dihydrate, Potassium Chloride, Magnesium Chloride, and Water for Injection. It is sterile, nonpyrogenic, and should not be used with blood or blood products. The container must be checked for leaks before use and unused portions should be discarded. It is distributed by Hospira, Inc. The recommended storage is at room temperature and the usual dosage should be obtained from the package insert.*
Hextend 04
This is a label on a medical container that instructs the user to tear at the notch to open it. The container does not require any ink or copying. It also warns the user to check for leaks before use, discard if found, and store at room temperature while protecting from freezing and excessive heat. The label also indicates that the container does not contain natural rubber latex.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
